DYSF mutation analysis in a group of Chinese patients with dysferlinopathy

https://doi.org/10.1016/j.clineuro.2012.11.010Get rights and content

Abstract

Objective

Dysferlinopathies belong to heterogeneous group of autosomal recessive muscular disorders caused by mutations in the gene encoding dysferlin. The classifications of the dysferlinopathies mainly include limb-girdle muscular dystrophy 2B (LGMD2B) with predominantly proximal weakness, Miyoshi myopathy (MM) with calf muscle weakness and atrophy, and distal myopathy with anterior tibial onset (DMAT) with tibialis muscle atrophy. We describe the genetic character of dysferlinopathies in a group of Chinese patients.

Methods

DYSF mutations screening were done after muscle biopsy and immunohistochemical staining.

Results

Eight patients showed an absence or drastic decrease of dysferlin expression in biopsied muscle. We identified 6 different mutations, including one nonsense mutation, two insertion mutation, two deletion mutations and one splice site mutation. Five of them were novel mutations.

Conclusion

We described 8 Chinese patients with dysferlinopathy (four had a distal phenotype of MM; one had a phenotype of DMAT and three presented with LGMD2B). It is the first report of genetic confirmed DMAT in China. Mutations c.3112C>T and c.1045dup, may be recurrent mutations in China.

Introduction

Dysferlin is a 230 kDa transmembrane protein and has been shown to be involved in the process of membrane repair [1], myoblast differentiation [2], T tubulogenesis [3] and muscle regeneration [4] through mechanisms of membrane organisation. Dysferlinopathies refer to a group of autosomal recessive muscular dystrophies caused by mutations in DYSF. Mutations in DYSF lead to different clinical phenotypes of muscular dystrophy according the distribution of affected muscles. It encompasses limb-girdle muscular dystrophy (LGMD2B), Miyoshi myopathy (MM), distal myopathy with anterior tibial onset (DMAT), isolated hyperCK and rigid spine syndrome. LGMD2B is characterized by predominant weakness and atrophy of muscles of the pelvic and shoulder girdle, onset in the late teens or later. LGMD2B is the second more frequent form of LGMD in Western countries [5] and Japan [6]. In China, LGMD has not been adequately studied, and its epidemiology remains unclear. MM is an early-adult onset, distal muscular dystrophy, characterized by predominant involvement in the calf muscles [7]. DMAT is a distal muscular dystrophy, characterized by predominant involvement in the anterior compartment group [8]. There are very few reports regarding dysferlinopathy in the Chinese population. In this study, we performed mutation analysis of DYSF in 8 Chinese patients with a dysferlin protein deficiency; the clinical and pathological features were collected and analyzed.

Section snippets

Materials and methods

We analyzed 8 Chinese patients from 8 unrelated families. Inclusion criteria for patients were: (i) clinical phenotype consistent with LGMD or distal myopathy, and (ii) metabolic myopathies or congenital myopathies were excluded, and (iii) loss or strong reduction of dysferlin expression evidenced by immunohistochemistry on muscle biopsy.

Mutational analysis of the DYSF gene

We performed a genomic analysis of the DYSF coding sequence in 8 unrelated Chinese patients based on a marked or total loss of dysferlin expression in muscle, demonstrated by immunohistochemistry on muscle sections. We identified 6 different mutations that included one nonsense mutations; two deletions, two insertions and one splice site mutations. Five of them were novel mutations. Three patients carried a single homozygous mutation; one patient had two compound heterozygous mutations; three

Discussion

Mutations in DYSF cause different clinical phenotypes of muscular dystrophy and the distribution of affected muscles is different between patients. Some patients show onset in proximal muscles, while others show initial selective atrophy and weakness of calf muscles or anterior tibial muscles. DYSF gene mutation analysis was carried out in 8 Chinese patients, who had drastic or complete protein deficiency on muscle sections. We have identified 6 variations in the DYSF gene, 5 of them being

References (20)

There are more references available in the full text version of this article.

Cited by (11)

View all citing articles on Scopus
View full text